Skip to content

Understanding clot structure in thrombosis and bleeding disorders

Understanding clot structure in thrombosis and bleeding disorders - Understanding clot structure in thrombosis and bleeding disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57046
Enrollment
30
Registered
2024-10-04
Start date
2024-09-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bleeding disorder cardiovascular disease thrombosis

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Voluntarily particiation, Between 18-70 of age, Written informed consent

Exclusion criteria

Exclusion criteria: Known disease that affects coagulation; Treatment with medication that interferes with coagulation

Design outcomes

Primary

MeasureTime frame
In this fundamental research project, we study determinants of the clot structure and how they affect the clot architecture and physical properties. For example, the stiffness of the clot, fiber diameters, rate of fibrinolysis and interaction of coagulation factors with cells or the endothelium will be studied in varying conditions (e.g. modified fibrinogen, presence or absence of flow).

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)